牛β-乳球蛋白基因调控序列指导组织型纤溶酶原激活剂在小鼠乳腺中的表达

用全长8.4kb的牛β-乳球蛋白基因(BLG)作为调控序列,用1.6kb的鸡溶菌酶MAR序列作为对抗转基因中位点效应的工具,构建了组织型纤溶酶原激活剂(tPA)乳腺表达载体。对2300枚卵进行显微注射,经PCR和Southern\|Blot检测,在170只出生小鼠中获得9只整合有牛BLG-tPA融合基因的转基因小鼠,并在转基因小鼠乳汁中检测到tPA的活性,tPA的表达水平最高达到12μg/mL。整合在小鼠基因组中的牛BLGtPA融合基因能稳定地遗传给子代。     

组织纤溶酶原激活剂突变体在转基因小鼠乳腺中的表达

组织纤溶酶原激活剂(tPA)是一种较理想的溶血栓药物,本研究采用其突变体——长效组织纤溶酶原激活剂(LAtPA)的cDNA作为目的基因,将它插入羊β-乳球蛋白(BLG)基因起始密码之前,使LAtPA的转录、翻译受控于BLG基因的5′、3′序列,再将所构建的BLG-LAtPA用显微注射方法建立转基因鼠,经点杂交筛选和Southern印迹鉴定,获得2只LAtPA基因整合阳性鼠,并在阳性母鼠乳汁中检测到有溶纤活性的LAtPA表达,表达水平1.5μg/ml。在这两只转基因鼠的9只F1代子鼠中,有5只是阳性的,tPA表达水平维持在1～2μg/ml,BLGtPA融合基因整合到小鼠基因组,能稳定地遗传给子代。     

转基因小鼠乳腺表达长效组织纤溶酶原激活剂

组织纤溶酶原激活剂(tPA)是一种较理想的溶血栓药物,本研究采用其突变体长效组织纤溶酶原激活剂(LAtPA)的cDNA作为目的基因,将其插入羊β-乳球蛋白(BLG)基因起始密码之前,使LAt-PA的转录、翻译受控于BLG基因的5′、3′序列,将此构建BLG-LAtPA用显微注射方法建立转基因鼠,经点杂交筛选和DNA印迹鉴定,获得2只LAtPA基因整合阳性鼠,并在阳性母鼠乳汁检测到有溶纤活性的LAtPA表达,表达水平1.5μg/ml。在这两只转基因鼠的F1代子鼠中,9只中有5只是阳性的,tPA表达水平维持在1-2μg/ml,说明BLG-tPA融合基因整合到小鼠基因组,能稳定地遗传给子代。为今后利用牛、羊作为生物反应器表达LAtPA奠定了基础。     

组织纤溶酶原激活剂突变体乳腺表达载体构建及在转基因鼠中表达的研究

通过PCR方法从羊肝总DNA中获得了羊β-乳球蛋白(BLG)基因第一和第二内含子,以羊β-乳球蛋白基因(BLG)5′区5kb为调控序列,构建了乳腺表达组织纤溶酶原激活剂突变体(La-tPA)载体。对540枚小鼠受精卵进行显微注射,经PCR和Southern blot检测,获得6只整合有人La-tPA的转基因小鼠,整合率为32%。同时研究了转基因在小鼠体内的表达。Northern blot分析表明,在一些转基因鼠乳腺中表达出La-tPA。在基因鼠乳汁中检测出La-tPA的表达达6μg/mL。这为未来利用转基因动物生产La-tPA提供依据。     

La-tPA/G-CSF双转基因鼠的建立及在乳腺的表达研究

分别以小鼠乳清酸蛋白 (WAP)基因 5′区 2 .6kb和羊β 乳球蛋白 (BLG)基因5′区 5kb为调控序列 ,构建了乳腺表达人集落剌激因子 (G -CSF)及组织纤溶酶原激活剂突变体 (La- tPA)载体 .利用显微注射法分别建立了G -CSF和La -tPA的转基因小鼠 ,在获得G -CSF和La -tPA表达基础上 ,采用 2种转基因小鼠交配的方式 ,对后代仔鼠进行了双引物同步PCR检测 ,筛选并建立了La- tPA和G -CSF的双转基因鼠 ,研究了不同转基因在小鼠体内共表达的情况 .Northernblot分析表明 ,在一些双转基因鼠中表达出La- tPA和G -CSF .后代鼠的一些基本特征为 ,产仔数明显低于正常鼠 ,双转基因占 46 .1 %,雌雄比例基本正常 .双转基因鼠的建立为未来利用转基因动物生产多种蛋白质提供依据 .     

ＢＬＧ—ＬＡtPA和鼠ＷＡＰ共注射提高ＬＡtPA在转基因小鼠乳腺中的表达水平

为了提高长效组织纤溶酶原活剂（ＬＡtPA）在转基因小鼠乳腺中的表达水平,将受控于羊β－乳球蛋白（ＢＬＧ）的ＬＡtPA表达载体ＢＬＧ－ＬＡtPA与小鼠乳清酸蛋白（ＷＡＰ）基因片段进行共注射,采用此方法建立的转基因小鼠,经ＰＣＲ筛选和Ｓouthern印迹鉴定,获得３只ＬＡtPA和ＷＡＰ共整合阳性鼠,并在阳性母鼠乳汁中检测到有溶纤活性的ＬＡtPA表达,表达水平达到１０μg/mL。     

组织纤溶酶原激活剂突变体乳腺表达载体构建及在转基因鼠中表 …

通过ＰＣＲ方法从羊肝总ＤＮＡ中获得了羊－β乳球蛋白（ＢＬＧ）基因第一和第二内含子,以羊β－乳球蛋白基因（ＢＬＧ）５’区５ｋｂ为调控序列,构建了乳腺表达组织纤溶酶原激活剂突变体载体。对５４０枚小鼠受精卵进行显微注射,经ＰＣＲ和Ｓｏｕｔｈｅｒｎ ｂｌｏｔ检测,获得６只整合有人Ｌａ－ｔＰＡ的转基因小鼠,整合率为３２％。同时研究了转基因在小鼠体内的表达。Ｎｏｒｔｈｅｒｎ ｂｌｏｔ分析表明,在一些转基因鼠乳     

牛BLG基因5＇调控成分的克隆和制备乳腺生物反应器研究

用PCR法克隆了牛β-乳球蛋白(BLG)基因的 1个片段,它包括 650 bp的 5’侧翼序列,第一二外显子和第一内含子.以该片段中的 650 bP的侧翼序列及转录起始位点下游 11 bP的非编码区(共 661 bP)作为调控序列,与人生长激素(hGH)基因构建成了表达载体,在培养的原代山羊乳腺上皮细胞中进行暂时表达,结果在激素诱导下, hGH基因能够表达,并且表达产物的绝大部分分泌到培养基中.将上述表达载体中的BLG/hGH融合基因部分经显微注射法制得5只转基因阳性小鼠,其中1只小鼠乳清中hGH的含量为420 μg/mL而血清中仅为0.051μg/mL,说明本实验克隆的牛BLG基因5’调控序列可以控制目的基因在转基因动物中表达,基本上具有乳腺特异性,而且产物能分泌至乳汁中.     

组织纤溶酶原激活剂突变体(La-tPA)转基因鼠的建立

用羊β－乳球蛋白基因（ＢＬＧ）５区５×１０３ｂ（１０３ｂ,旧称ｋｂ）为调控序列,构建了乳腺表达组织纤溶酶原激活剂突变体（Ｌａ－ｔＰＡ）载体．对５４０枚小鼠受精卵进行显微注射,经ＰＣＲ和Ｓｏｕｔｈｅｒｎｂｌｏｔ检测,获得６只整合有人Ｌａ－ｔＰＡ的转基因小鼠,整合率为３２％．这为未来利用转基因动物生产Ｌａ－ｔＰＡ提供依据     

山羊β乳球蛋白基因的克隆及其在转基因小鼠乳汁中的高效表达 Goat β-lactoglobulin Gene Cloning and High Expression in the Mammary Gland of Transgenic Mice

通过长距离PCR从山羊基因组DNA分两段扩增山羊β乳球蛋白（β-lactoglobulin,BLG）基因,扩增出的两个片段分别克隆到T载体上,利用BLG基因序列自身存在的NarI单酶切位点进行拼接,获得了全长为7.2kb的山羊BLG基因克隆,并构建了它的真核表达载体,经酶切鉴定和序列分析证实了克隆的正确性。用线性化的BLG基因显微注射小鼠受精卵以建立转基因鼠,经PCR和Southern印迹分析证实获得了6只首建者（Founder）转基因小鼠（3♀,3♂）,在泌乳期采集两只F0代转基因雌鼠乳汁并用ELISA测定山羊β乳球蛋白的含量,其表达水平分别为23.49 mg/mL和2.19 mg/mL。 Abstract:To clone goat β-lactoglobulin (BLG) gene,two fragments were amplified from goat genomic DNA by LD-PCR method.The fragments were inserted in T-vectors before being spliced into the whole 7.2 kb BLG gene at a single restriction enzyme site of NarI.Consequently,the eukaryotic expression vector was constructed.All the clones were proved to be correct by restriction enzyme cutting and sequencing analysis.Six Founders (3♀,3♂) of goat BLG transgenic mice were obtained by microinjection and BLG genes integration were confirmed by both PCR and Southern blot analyses.The milk was collected from two lactating female transgenic mice and goat BLG protein contents were measured with ELISA.The results showed that goat BLG protein in milk of the two mice were 23.49 mg/mL and 2.19 mg/mL,respectively.     

Analysis of tissue-specific expression of human type II collagen cDNA driven by different sizes of the upstream region of the beta-casein promoter

To investigate the ability of 1.8 kb or 3.1 kb bovine beta-casein promoter sequences for the expression regulation of transgene in vivo, transgenic mice were produced with human type II collagen gene fused to 1.8 kb and 3.1 kb of bovine beta-casein promoter by DNA microinjection. Five and three transgenic founder mice were produced using transgene constructs with 1.8 kb and 3.1 kb of bovine beta-casein promoters respectively. Founder mice were outbred with the wild type to produce F1 and F2 progenies. Total RNAs were extracted from four tissues (mammary gland, liver, kidney, and muscle) of female F1 transgenic mice of each transgenic line following parturition. RT-PCR and Northern blot analysis revealed that the expression level of transgene was variable among the transgenic lines, but transgenic mice containing 1.8 kb of promoter sequences exhibited more leaky expression of transgene in other tissues compared to those with 3.1 kb promoter. Moreover, Western blot analysis of transgenic mouse milk showed that human type II collagen proteins secreted into the milk of lactating transgenic mice contained 1.8 kb and 3.1 kb of bovine beta-casein promoter. These results suggest that promoter sequences of 3.1 kb bovine beta-casein gene can be used for induction of mammary gland-specific expression of transgenes in transgenic animals.     

牛乳铁蛋白肽转基因小鼠的构建

目的:探讨牛乳铁蛋白肽在转基因鼠乳汁中的表达及其抑菌活性。方法:将实验室构建并保存的包含山羊β-酪蛋白基因启动子和牛乳铁蛋白肽基因的乳腺特异表达载体PI-bcp-LfcinB,用Xho I和Nru I双酶切,得到含有全部表达盒的显微注射DNA片段,采用常规显微注射技术获得转基因小鼠。并通过对泌乳期转基因雌鼠乳腺组织的RT-PCR检测,确定了牛乳铁蛋白肽在mRNA水平的表达,同时利用琼脂板扩散法检测了转基因鼠乳汁中表达产物的抑菌活性。结果:获得了牛乳铁蛋白肽转基因小鼠,且转基因小鼠乳汁中能够表达具有抑菌活性的牛乳铁蛋白肽。结论:通过转基因动物乳腺可以获得具有生物活性的牛乳铁蛋白肽,为进一步研究抗菌肽转基因牛、培育抗乳房炎奶牛新品种以及通过建立转基因动物生物反应器进行抗菌肽的大量生产奠定了基础。     

Accurate spatial and temporal transgene expression driven by a 3.8-kilobase promoter of the bovine β-casein gene in the lactating mouse mammary gland

The spatial, temporal, and hormonal pattern of expression of the β-casein gene is highly regulated and confined to the epithelial cells of the lactating mammary gland. Previous studies have shown that 1.7 kb of the bovine β-casein promoter were able to drive cell-specific and hormone-dependent expression to a mouse mammary cell line but failed to induce accurate expression to the mammary gland of transgenic mice. We investigated here the ability of 3.8 kb of the bovine β-casein gene promoter to drive the expression of the human growth hormone (hGH) gene in transgenic mice. A Northern blot analysis using total RNA obtained from different tissues of lactating and nonlactating females revealed the presence of hGH mRNA only in the mammary gland of lactating females. hGH mRNA was not detectable in the mammary gland of virgin females or males. A developmental analysis showed that hGH mRNA only peaked on parturition, resembling more closely the bovine β-casein temporal expression pattern rather than the murine. In situ hibridization studies performed on mammary gland sections showed that the cellular pattern of hGH expression was homogeneous in all lobules from heterozygous and homozygous transgenic mice. Silver grain counts on the tissue sections highly correlated with the hGH contents in the milk determined by radioimmunoassay (r = 0.996). Thus 3.8 kb of the bovine β-casein promoter direct a high-level expression of a reporter gene to the lactating mammary gland of transgenic mice in a tissue-specific and developmentally regulated manner. Mol. Reprod. Dev. 49:236–245, 1998. © 1998 Wiley-Liss, Inc.     

转基因小鼠乳腺表达G-CSF的研究

用PCR法从正常中国人脐带血提取总DNA作为模板,扩增出1.5 kb的人G-CSF基因组基因。序列分析证实其正确性。将其插入小鼠乳清酸蛋白(WAP)基因的起始密码子ATG前的KpnⅠ位点,使其受控于2.6kb的WAP调控序列,构建成乳腺表达载体pWGG。回收经EcoRⅠ酶切后的8.7kb片段用于显微注射。共注射1200枚受精卵,移植34受体母鼠,产仔鼠85只。经PCR检测和DNA印迹分析,证实获得两只整合有人G-CSF基因的雄性鼠,整合率为2.37％。建立的转基因鼠系表明,采用ELASA方法对F1代雌鼠乳汁检测,成功地表达出人G-CSF。表达量为120～250ng/ml。这一结果表明转基因的表达具有乳腺特异性。这为在大动物中实施转基因提供了依据。     

High level expression of the bioactive human interleukin-10 in milk of transgenic mice

Human interleukin-10 (hIL-10) has wide spectrum of anti-inflammatory activities and has shown a potential to be used for treatment of inflammatory or immune illness. In this study, transgenic mice that over-express human interleukin-10 (IL-10) in their milk were generated using a bovine beta-casein/human IL-10 hybrid gene. After cloning of the IL-10 gene, a 22 kb hybrid gene was constructed by linking a 10 kb promoter sequence of the bovine beta-casein gene to the cloned 12 kb IL-10 gene. In six of the eight transgenic mice, the transgene RNA was expressed only in the mammary gland and in the other two mice, it was also slightly expressed in the lung. The highest human IL-10 level in milk was 1620 microg x ml(-1). Notably, transgenes in all the eight transgenic mice were expressed regardless of the integration site even though no correlation was shown between the copy numbers of the transgene and expression level. These results suggest that the genomic sequence of the human IL-10 gene can induce the IL-10 expression at high levels under the control of the bovine beta-casein promoter.     

新城疫病毒融合蛋白在转基因水稻叶片中的表达及其免疫原性

利用转基因植物作为生物反应器表达抗原蛋白具有广阔的应用前景。以新城疫病毒融合蛋白（NDVF）基因1.7kb全长编码区序列为外源基因与组成型表达的玉米泛素蛋白基因（Ubi）启动子和农杆菌胭脂碱合成酶基因（nos）终止子组成嵌合基因,构建了适宜于农杆菌介导转化水稻的转化载体pUNDV,经根癌农杆菌介导的遗传转化方法将由Ubi动子驱动的NDVF嵌合基因导入水稻细胞中,经潮霉素抗性筛选,共再生获得了6个独立的转基因株系。PCR分析结果表明NDVF基因已整合到水稻基因组中。ELISA和Western blot分析结果证实NDVF蛋白在部分转基因水稻叶片组织中获得表达,其中植株F5叶片组织中具有较高的表达水平。将F5叶片可溶性总蛋白皮下注射免疫BALB／c小鼠,结果表明能够诱导小鼠产生一定水平的NDVF蛋白特异抗体。     

High-level expression of human lactoferrin in milk of transgenic mice using genomic lactoferrin sequence.

In our previous study, transgenic mice were generated that expressed human lactoferrin (hLF) in milk using cDNA under control of the 2 kb bovine beta-casein promoter. The expression level of the protein in milk of 7 mice ranged from 1 to 200 microg/ml; 1 to 34 microg/ml in 6 mice and 200 microg/ml in 1 mouse. With the aim of inducing higher expression of the protein, we constructed an expression cassette comprised of 10 kb of the bovine beta-casein gene promoter and the hLF genomic sequence in place of the cDNA. The hLF genomic sequence of about 27 kb, spanning 23 kb of the entire coding region and 4 kb of the 3'-flanking sequence, was placed downstream the bovine beta-casein promoter. In total, 8 transgenic mice were generated from 31 mice (transgenic rate of 25.8%) born from the embryos microinjected with the 40-kb hLF expression cassette. Mammary-specific expression of the transgene was addressed by performing Northern hybridization of the total RNAs from various tissues of transgenic mice. Immunoblot analysis showed that the recombinant protein expressed in milk has the same molecular weight as the native protein. The amount of the protein in milk of 5 mice ranged from 60 to 6,600 microg/ml when judged by ELISA analysis. Three mice expressed the protein at the level higher than 500 microg/ml. These data suggest that the genomic lactoferrin sequence represents a valuable element for the efficient expression of the protein in milk of transgenic animals.     

表达乙肝病毒受体人ASGPR转基因小鼠的建立

目的：建立表达乙肝病毒受体人ASGPR的转基因小鼠。方法：克隆人的脱唾液酸糖蛋白受体（ASGPR）两个亚基的cDNA,连入PCAGGS构建转基因表达载体,以显微共注射的方法将两种各3.9kb的转基因片段引入小鼠的受精卵。采用PCR、Southern印迹、RT-PCR、Western印迹的方法对转基因小鼠进行鉴定。结果与结论：获得了在小鼠肝脏组织中共表达有乙肝病毒（HBV）受体ASGPR H1和ASGPR H2的一个转基因小鼠系,可为HBV的研究提供一种良好的感染动物模型。     

Production of transgenic mice and rabbits that carry and express the human tissue plasminogen activator cDNA under the control of a bovine alpha S1 casein promoter

One-cell embryos from mice and rabbits were microinjected with a hybrid gene composed of 1.6 kilobases (kb) promoter/regulatory sequences of the bovine alphaS1 casein gene fused to the complementary DNA (cDNA) encoding for the human tissue plasminogen activator (htPA) and 3'untranslated sequences from rabbit beta-globin and SV 40 genes. Transgenic mice and rabbits that carry the htPA gene were obtained. In mice, 11 founder females were generated, and 6 of them expressed low levels (about 50 mug/ml) of htPA in their milk. Some of the transgenic mice showed rearrangements of the microinjected DNA sequences as judged by Southern blot analysis. A position-dependent expression of the transgene is suspected to occur. The only live-born founder transgenic rabbit obtained was a male, and it transmitted the transgene in a Mendelian fashion to F1 females, which expressed htPA at very low levels (8 to 50 ng/ml). Although the 1.6-kb bovine alphaS1 casein promoter that was used directs the synthesis of htPA specifically to the mammary gland, it may not be sufficient for a high level of expression.